Molecular and phenotypic heterogeneity of triple-negative breast cancers

被引：0
|
作者：
Bae, Y. K.
Kang, S. H.
Lee, S. J.
Gabrielson, E.
机构：
[1] Yeungnam Univ, Coll Med, Taegu, South Korea
[2] Johns Hopkins Sch Med, Baltimore, MD USA
来源：
MODERN PATHOLOGY | 2008年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
80
引用
收藏
页码：20A / 20A
页数：1
相关论文
共 50 条
  • [41] Triple-Negative Breast Cancers: Different Sensitivity to Chemotheray
    Choi, Y. L.
    Oh, E.
    Kim, Y.
    Park, Y. H.
    Cho, E. Y.
    Lee, J. E.
    Kim, J. H.
    Nam, S. J.
    Lim, Y. H.
    Yang, J. H.
    Shin, Y. K.
    Hong, Y. C.
    [J]. LABORATORY INVESTIGATION, 2010, 90 : 41A - 41A
  • [42] Epigenetic heterogeneity in triple-negative breast cancer.
    Maruyama, Reo
    Yang, Liying
    Kumegawa, Kohei
    [J]. MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 29 - 30
  • [43] PDJ amplicon heterogeneity in triple negative breast cancers
    Roesler, Alexander S.
    Malasi, Smriti
    Lenkiewicz, Elizabeth
    Pockaj, Barbara A.
    Lewis, Michael T.
    Dobrolecki, Lacey E.
    Koslosky, Lori
    Hartmayer, Peter
    Anderson, Karen S.
    Barrett, Michael T.
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [44] Heterogeneity and transcriptional drivers of triple-negative breast cancer
    Jovanovic, Bojana
    Temko, Daniel
    Stevens, Laura E.
    Seehawer, Marco
    Fassl, Anne
    Murphy, Katherine
    Anand, Jayati
    Garza, Kodie
    Gulvady, Anushree
    Qiu, Xintao
    Harper, Nicholas W.
    Daniels, Veerle W.
    Huang, Xiao-Yun
    Ge, Jennifer Y.
    Aleckovic, Masa
    Pyrdol, Jason
    Hinohara, Kunihiko
    Egri, Shawn B.
    Papanastasiou, Malvina
    Vadhi, Raga
    Font-Tello, Alba
    Witwicki, Robert
    Peluffo, Guillermo
    Trinh, Anne
    Shu, Shaokun
    Diciaccio, Benedetto
    Ekram, Muhammad B.
    Subedee, Ashim
    Herbert, Zachary T.
    Wucherpfennig, Kai W.
    Letai, Anthony G.
    Jaffe, Jacob D.
    Sicinski, Piotr
    Brown, Myles
    Dillon, Deborah
    Long, Henry W.
    Michor, Franziska
    Polyak, Kornelia
    [J]. CELL REPORTS, 2023, 42 (12):
  • [45] Analysis of epigenetic heterogeneity in triple-negative breast cancer
    Maruyama, Reo
    Yang, Liying
    Kohei, Kumegawa
    Nakadai, Tomoyoshi
    [J]. CANCER SCIENCE, 2018, 109 : 1249 - 1249
  • [46] NF-B Is a Potential Molecular Drug Target in Triple-Negative Breast Cancers
    Poma, Paola
    Labbozzetta, Manuela
    D'Alessandro, Natale
    Notarbartolo, Monica
    [J]. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2017, 21 (04) : 225 - 231
  • [47] Rates of immune infiltration in patients with triple-negative breast cancers by molecular subtype and in patients with inflammatory and noninflammatory breast cancers
    Harano, K.
    Wang, Y.
    Lim, B.
    Seitz, R. S.
    Morris, S. W.
    Bailey, D. B.
    Hout, D. R.
    Skelton, R. L.
    Ring, B. Z.
    Masuda, H.
    Rao, A. U. K.
    Woodward, W. A.
    Reuben, J. M.
    Ueno, N. T.
    [J]. CANCER RESEARCH, 2017, 77
  • [48] Unraveling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis
    Bareche, Yacine
    Venet, David
    Aftimos, Philippe
    Ignatiadis, Michail
    Piccart, Martine
    Rothe, Francoise
    Sotiriou, Christos
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [49] Modelling the spatial heterogeneity and molecular correlates of lymphocytic infiltration in triple-negative breast cancer
    Yuan, Yinyin
    [J]. JOURNAL OF THE ROYAL SOCIETY INTERFACE, 2015, 12 (103)
  • [50] Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis
    Bareche, Y.
    Venet, D.
    Ignatiadis, M.
    Aftimos, P.
    Piccart, M.
    Rothe, F.
    Sotiriou, C.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 (04) : 895 - 902
12345